vimarsana.com

Latest Breaking News On - Quarter for apellis pharmaceuticals - Page 1 : vimarsana.com

Frazier Life Sciences Management L P Acquires 271,122 Shares of Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

Frazier Life Sciences Management L.P. lifted its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 44.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 885,165 shares of the company’s stock after acquiring an additional 271,122 shares during the […]

KPP Advisory Services LLC Has $670,000 Position in Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

KPP Advisory Services LLC raised its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 17.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,196 shares of the company’s stock after buying an additional 1,675 shares during the quarter. KPP […]

KPP Advisory Services LLC Raises Stake in Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

KPP Advisory Services LLC boosted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 17.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,196 shares of the company’s stock after purchasing an additional 1,675 shares during the quarter. KPP Advisory Services LLC’s […]

Rhenman & Partners Asset Management AB Decreases Position in Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

Rhenman & Partners Asset Management AB lessened its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 53.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 100,400 shares of the company’s stock after selling 114,600 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Apellis Pharmaceuticals were […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.